FindTrial
Sign In

Effects of Niaoduqing particles on residual renal function and quality of life in peritoneal dialysis patients based on real-world research

Effects of Niaoduqing particles on residual renal function and quality of life in peritoneal dialysis patients based on real-world research

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070967
Enrollment
Unknown
Registered
2023-04-27
Start date
2023-05-01
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage renal disease

Interventions

Niaoduqing particles group:N/A
Control group :N/A

Sponsors

Yixing People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Aged at least 18 years; 2) Regular peritoneal dialysis was performed and urine volume greater than 100ml at 24 hours; 3) Patients who insist on re-examination of relevant indicators every 3 months

Exclusion criteria

Exclusion criteria: 1)Patients with history of hemodialysis or kidney transplantation; 2) History of malignant tumor; 3) Niaoduqing particles or drugs containing rhubarb were used within 1 month before enrollment; 4) There are serious digestive tract diseases that affect drug absorption, such as active ulcers; chronic diarrhea; gastrointestinal surgery; 5) Mental patients

Design outcomes

Primary

MeasureTime frame
Quality of life;residual renal function;—

Secondary

MeasureTime frame
the degree of pruritus;serum calcium;serum phosphorus;serum parathyroid hormone;serum hemoglobin;—

Countries

China

Contacts

Public ContactPenghua Hu

Yixing People's Hospital

hupenghua2010@126.com+86 18795697075

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026